Tag: CBT > Medical Marijuana and Cannabidiol Research Expansion Act

Industry Headlines

MMJ to File Emergency Injunction Against DEA’s ‘Unconstitutional Marijuana Hearing’

MMJ BioPharma Cultivation, a company seeking DEA registration to cultivate cannabis for research, is hoping to avoid an administrative hearing.

May 1, 2025

Cannabis Industry Research

Medical Marijuana Act Signed by Biden Would Hinder Research Under Rescheduling

The Medical Marijuana and Cannabidiol Research Expansion Act’s requirements would remain under Schedule III, a congressional researcher says.

September 20, 2024

Industry Headlines

MMJ BioPharma Suing DEA Over Cannabis Reform, Medical Research

The biopharmaceutical company filed a lawsuit, citing ‘unjustified’ delays in processing an application for medical research.

September 11, 2024

Cannabis Rescheduling

Biden’s Failed Actions on Cannabis Issues ‘Borders on Political Malpractice,’ Lawmaker Says

Rep. Earl Blumenauer asked Health Secretary Xavier Becerra to relay his concerns on cannabis reform to the president during a committee hearing.

March 22, 2024

Top Stories

Lawmakers 'Deeply Concerned' About Medical Cannabis Act's Implementation

Congressmen Earl Blumenauer and Andy Harris sent a letter requesting answers from the DEA and HHS on barriers to cannabis research and the government agencies’ missed report deadline that is required by the Medical Marijuana and Cannabidiol Research Expansion Act.

March 12, 2024